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ABSTRACT
Introduction: Catastrophizing is the tendency to magnify the threat value of pain and 
has been associated with measures of physical and psychological disability among 
individuals with several pain conditions. The aim of this study was to investigate 
whether pain catastrophizing is differentially associated with distinct pain syndromes.
Methods: This is a cross-sectional study including 158 patients (40 with fibromyalgia, 
25 with myofascial pain syndrome, 33 with chronic tensional type headache, 33 with 
endometriosis, and 27 with knee osteoarthritis) and 93 healthy subjects. The recruitment 
procedure occurred in concurrence with randomized controlled trials. Participants 
answered the following instruments: Brazilian Portuguese Pain-Catastrophizing Scale, 
Beck Depression Inventory II, State-Trait Anxiety Inventory, Pittsburgh Sleep Quality 
Index, visual analogue scale for pain, as well as a sociodemographic questionnaire.
Results: For the total pain catastrophizing score, patients with endometriosis had 
significantly more catastrophizing thoughts than knee osteoarthritis (p < 0.05). Healthy 
participants had lower scores than any clinical group. More interestingly were the 
dimensions of pain catastrophizing, which showed significant differences in more 
than two groups, especially magnification scores, since these scores were able to 
discriminate, in a particular way, the majority of clinical samples from each other. 
We also observed differences between rumination, magnification and helplessness 
scores in all groups, suggesting that the characteristics of pain catastrophizing are 
distinct according to the pain disorder.
Conclusions: The results suggest that dimensions of pain catastrophizing differ 
between pain syndromes. Therefore, it is important that researchers and clinicians 
focus on cognitive and emotional aspects of pain perception to have more successful 
interventions.
Keywords: Chronic pain; catastrophizing; cross-sectional study
Pain is a multidimensional sensory experience that is intrinsically unpleasant 
and associated with hurting and soreness1. Chronic pain is a maladaptive 
neuroplasticity process that manifests itself in many different pathological 
changes in the nervous system function, affecting 30% of the worldwide 
population2. Chronic pain reduces quality of life and causes an expressive 
social and economic burden. Widespread chronic pain has an estimated 
prevalence of 14.2%3.
It is well established that central sensitization phenomenon involves impaired 
functioning of brain-orchestrated descending inhibitory mechanisms and can 
alter pain facilitatory pathways4,5, causing changes in sensory processing 
centers of the brain4. These neuroplastic changes can modify behavioral and 
emotional aspects when one is experiencing chronic pain6, being associated 
with clinical and psychological symptoms7.
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It has been evidenced that pain may play an 
important role in the development of negative 
emotional reactions, such as temporary or chronic 
anger, depression, loneliness, and anxiety. These 
emotions can modify the subjective experience of pain, 
amplifying the pain signaling process. Chapman and 
Nakamura8 described negative emotions as one of the 
most important characteristics of pain. Furthermore, 
some psychological factors, such as somatization, 
helplessness, and catastrophizing, might exacerbate 
chronic pain conditions and worsen prognosis9-11.
The concept of catastrophizing was first described 
nearly 40 years ago and aims to define the tendency 
to magnify the threat value of pain and to feel helpless 
in this context associated with an inability to inhibit 
pain-related thoughts in anticipation of, during or 
following a painful situation12,13. Consequently, it 
has been suggested that catastrophizing is a stable, 
person-based trait14,15 that probably compromises 
therapeutic response and prognosis. Catastrophizing 
related to pain can be measured by the Pain 
Catastrophizing Scale (PCS), which allows a prompt 
identification of individuals at risk for psychological 
consequences that may need further psychosocial 
evaluation. The PCS assesses three dimensions of 
catastrophizing in response to pain: 1) rumination, 
2) magnification, and 3) helplessness14,16. The PCS has 
been broadly used in research and clinical practice. 
These studies have shown that catastrophizing is 
significantly correlated with the patient’s subjective 
experiences on the severity of pain and his or her 
disability due to pain. Besides, our group has reported 
the relationship between cortical excitability and pain 
catastrophizing, suggesting that catastrophizing 
responses may be related to neurophysiological 
mechanisms associated with chronic pain, since 
glutamatergic activity was associated with mechanisms 
underlying pain catastrophizing17. Altogether, the findings 
above emphasize the importance of conceptualizing 
catastrophizing in specific pain syndromes. Nevertheless, 
different profiles of pain catastrophizing remains 
unclear. Collectively,18 suggest that catastrophizing 
refers to numerous negative pain-related thoughts, 
including magnification of the severity of a pain 
perception, rumination thoughts related to pain, and 
helpless thoughts related to worrying about the worst 
possible consequences of pain.
Thus, the aim of this exploratory study was to 
investigate whether pain catastrophizing scores are 
differentially associated with distinct pain syndromes. 
To address this question we administered the PCS and 
examined its relation to pain syndrome, depression, 
anxiety, sleep quality, and levels of pain.
METHODS
The protocol was reviewed and data collection 
was approved by the Hospital de Clínicas de Porto 
Alegre Research Ethics Committee under protocol 
numbers: 10-0555, 14-0369, 14-0092, 10-0380, 
and 11-0013, according to the sample recruited. 
All patients provided written informed consent prior 
to their participation in this study.
Design Overview, Setting, and Participants
For this cross-sectional study, a total of 158 patients 
were determined to be eligible and agreed to participate: 
40 with fibromyalgia (FM), 29 with myofascial pain 
syndrome (MPS), 33 with chronic tensional type 
headache (CTTH), 33 with endometriosis, and 
27 with osteoarthritis (OA), in addition to 93 healthy 
volunteers. Chronic pain subjects recruited from local 
community care units, from an institutional chronic 
pain clinic, by referrals from other hospital units, and 
by phone and newspaper were included in the study. 
The recruitment procedure occurred in concurrence 
with some randomized controlled trials (RCTs) run at 
the Hospital de Clínicas de Porto Alegre, registered 
at https://clinicaltrials.gov, including studies with 
chronic pain disorders such as FM (NCT02041455, 
NCT01804097), MPS (NCT01964729), CTTH 
(NCT01954277), and knee osteoarthritis (KOA) 
(NCT01747070, NCT01855958).
Healthy volunteers were recruited from the 
general population by public postings. A standard 
screening questionnaire was developed in order 
to assess inclusion criteria. Eligible healthy control 
subjects had to be free of any acute or chronic pain; 
without recent use of analgesics, corticosteroids 
or psychotropic medications; and without any 
rheumatologic, psychiatric, or neurological disorders. 
Besides, healthy control volunteers were excluded 
if they reported alcohol or psychotropic substance 
abuse 6 months preceding the screening.
Diagnosis
A highly skilled physician trained to perform chronic 
pain assessment and treatment provided all diagnoses 
in the RCTs using standardized evaluation criteria. 
The diagnostic criteria for MPS included regional 
pain, normal neurologic examination, the presence 
of trigger points, taut bands, tender points, and pain 
characterized as “dull”, “achy”, or “deep”. OA diagnoses 
were made according to the clinical and radiographic 
criteria of the American College of Rheumatology19. 
Also, all OA patients completed the Western Ontario 
and McMaster universities OA index (WOMAC), a 
validated measure of OA-related patient-reported 
symptoms and perceived disability20. CTTH diagnosis 
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was made using the 2004 International Headache 
Society criteria21. FM diagnosis was made according 
to the American College of Rheumatology criteria 
for FM22. In all RCTs, patients were included if they 
had experienced pain scored as visual analog scale 
(VAS) > 40 mm (which is compatible to moderate 
or severe pain). Additionally, the pain needed to 
be associated with disability, as assessed by an 
affirmative answer to dichotomous questions (yes/no) 
of a structured questionnaire. Queries inquired if their 
pain had interfered with work, enjoyable activities, 
responsibilities at home, relationships, personal goals, 
thinking clearly, problem solving, concentration, or 
recall. Patients with rheumatologic or neurologic 
diseases (e.g.: stroke or Parkinson’s disease), 
surgical procedure on the pain-related areas in the 
prior 6 months, habitual use of corticosteroids, or 
any other uncompensated chronic pathology were 
excluded. Additionally, patients with any malignancy 




After signing informed consent, subjects were 
asked to complete a sociodemographic questionnaire 
that assessed variables including age, gender, work 
status due to pain, and educational level.
Pain assessment and psychological variables
The Brazilian Portuguese Pain-Catastrophizing 
scale (BP- PCS)23 was used to measure catastrophizing 
thoughts related to pain. This is a self-administered 
questionnaire composed by 13 items that evaluates 
self-reported catastrophizing thoughts, feelings, and 
behaviors when one is in pain. BP-PCS presents 
three major domains: helplessness, magnification, 
and rumination regarding pain. The scores of each 
one of the three domains are given by the sum of 
the corresponding items (magnification 6, 7, and 13; 
rumination 8–11; and helplessness 1–5 and 12). 
Items are rated on a 5-point Likert scale, grading 
both intensity and frequency information. Results are 
computed by summing all items on the questionnaire 
and total scores range from 0–52.
Depressive symptoms were assessed by the 
Beck Depression Inventory II, adapted to Brazilian 
Portuguese24, which is an instrument recommended 
by the Initiative on Methods, Measurement, and Pain 
Assessment in Clinical Trials since its psychometric 
properties are excellent and it is widely used in clinical 
pain research.
The State-Trait Anxiety Inventory (STAI) is a 
commonly used tool to measure trait and state 
anxiety25. It is often used in the research field to 
measure via self-report the presence and severity 
of current symptoms of anxiety and a generalized 
propensity to be anxious. A short version of the 
inventory, STAI-SV, was used in the present study26.
Sleep quality was evaluated using the Brazilian 
Portuguese version of the Pittsburgh Sleep Quality 
Index27, which has good psychometric properties, 
with a reliability coefficient (Cronbach’s α) of 0.82.
Pain intensity was evaluated through a visual 
analogue scale (VAS), a common and easy method 
to assess pain level. VAS results were converted to 
0 (no pain) to 10 (the worst pain possible). Researchers 
assessed the use of analgesics, defined by the 
average amount of analgesics used per week during 
the last month.
Statistical analysis
Descriptive and inferential statistics were used. After 
exploring data distribution, using Kolmogorov-Smirnov 
and Shapiro-Wilk tests, as well as inspection of 
histogram, we verified that the main outcomes 
did not meet parameters of normal distribution. 
Nevertheless, after comparing parametric and 
non-parametric approaches for group comparison and 
repeated-measures comparisons, analyses yielded 
the same results. Therefore, we used parametric 
descriptive (mean, standard deviation) and inferential 
analyses (analyses of variance [ANOVAs]). Due to 
several comparisons implemented, significance value 
was corrected according to the Bonferroni post-hoc test 
for intra-group comparisons and the Games-Howell 
post-hoc test for inter-group comparisons due to 
different sample sizes and violation of homogeneity. 
Pearson’s correlations were used to verify the relation 
between pain catastrophizing and other clinical 
measures.
RESULTS
General Characteristics of the Samples
Table 1 presents sociodemographic and health 
aspects of the samples. All variables were significantly 
different between groups (p < 0.05), especially for the 
clinical aspects (depression, anxiety, sleep quality 
and pain level) for the healthy subjects (HS) group, 
which have significantly fewer or none symptoms.
Comparisons of Pain Catastrophizing Scores 
Between Chronic Pain Syndromes
By means of one-way ANOVAs considering pain 
catastrophizing scores as dependent variables, there 
were significant differences between the studied 
groups, which can be noted in Table 2. Figure 1 
shows pairwise comparisons between every two 
groups as assessed by t-tests. The results suggest 
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Age (years) 30.4 (9.6) 49.6 (9.8) 46.0 (13.3) 37.6 (6.0) 40.2 (10.8) 64.7 (7.8)
Years of study 16.6 (3.3) 10.7 (3.6) 12.8 (3.5) 10.7 (2.8) 14.2 (3.5) 10.3 (5.6)
BMI (m/kg2) 24.0 (4.1) 22.6 (4.1) 20.7 (3.8) - 19.7 (2.7) -
BDI-II total 7.2 (7.8) 26.4 (11.6) 13.7 (9.5) - - 10.0 (7.2)
STAI - State 25.9 (6.3) 33.9 (6.9) 27.3 (8.3) - - -
STAI - Trait 22.3 (5.0) 60.1 (10.6) - - - -
PSQI 3.1 (2.0) 11.8 (4.2) 18.9 (7.4) 17.2 (7.2) 17.1 (6.8) -
VAS - pain 0.4 (1.1) 7.3 (1.6) 5.8 (3.2) 7.1 (2.8) 5.9 (1.5) 5.4 (2.5)
HS = healthy subjects; FM = fibromyalgia; MPS = myofascial pain syndrome; EM = endometriosis; CTTH = chronic tensional type headache; 
KOA = knee osteoarthritis; BMI = body mass index; BDI-II = Beck Depression Inventory; STAI = State Trait Anxiety Inventory; PSQI = Pittsburgh 
Sleep Quality Index; VAS = Visual Analogue Scale; SD = standard deviation.
Figure 1: Differences between groups for the scores of pain catastrophizing. HS = healthy subjects; FM = fibromyalgia; 
MPS = myofascial pain syndrome; EM = endometriosis; CTTH = chronic tensional type headache; KOA = knee osteoarthritis; 
BP:PCS = Brazilian Portuguese Pain Catastrophizing Scale; SEM = standard error of the mean. * = indicates significant 
differences (p < 0.05), according to Games-Howell post-hoc tests. † = indicates significant differences (p < 0.01), according 
to Games-Howell post-hoc tests between HS and all the other groups, except for magnification scores, in which HS, MPS 
and KOA patients were equivalent, and helplessness, in which HS and EM were equivalent.
Table 2: Descriptive and comparative statistics for pain catastrophizing measures according to the groups of chronic pain 
















BP:PCS total 13.7 (1.3) 31.4 (2.0) 27.5 (2.6) 33.4 (1.6) 30.7 (2.5) 22.9 (2.2) 21.89 < 0.001
BP:PCS rumination 5.3 (0.5) 11.8 (0.8) 9.7 (0.8) 11.7 (0.4) 10.5 (0.8) 8.0 (0.7) 21.38 < 0.001
BP:PCS 
magnification
3.0 (0.3) 8.7 (0.5) 5.3 (0.8) 14.3 (0.9) 6.5 (0.6) 4.4 (0.6) 55.13 < 0.001
BP:PCS 
helplessness
5.0 (0.5) 10.9 (0.9) 12.4 (1.2) 7.5 (0.5) 13.6 (1.2) 10.5 (1.1) 18.83 < 0.001
Within-group 
comparisons
F 28.56 103.84 16.08 222.00 9.65 8.24
p < 0.001 < 0.001 < 0.001 < 0.001 0.001 0.002
One-way analyses of variance (ANOVAs) were used for between-groups tests, and repeated-measures ANOVAs were used for within-group 
tests (the last included only the dimensions rumination, magnification and helplessness). HS = healthy subjects; FM = fibromyalgia; MPS = 
myofascial pain syndrome; EM = endometriosis; CTTH = chronic tensional type headache; KOA = knee osteoarthritis; BP:PCS = Brazilian 
Portuguese Pain Catastrophizing Scale; SD = standard deviation.
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all measures of pain catastrophizing differ between 
groups. These differences were not only evident for 
the comparison of HS and the clinical groups, but 
also differ between clinical samples. For the total 
score (Figure 1A), patients with EM had significantly 
more catastrophizing thoughts than those with KOA. 
More interestingly were the dimensions of pain 
catastrophizing (Figure 1B, C and D), which showed 
significant differences in more than two groups, 
specially magnification scores, since these scores 
were able to discriminate, in a particular way, all the 
clinical samples (Figure 1C).
Comparisons Between Rumination, 
Magnification and Helplessness Dimensions of 
Pain Catastrophizing
In order to investigate whether the studied 
groups had a more salient prevalent aspect of pain 
catastrophizing, we analyzed the scores of the 
subscales of BP:PCS using within-subjects tests. 
The scores were significant different in all groups, as 
presented in Table 1. We plotted pairwise comparisons 
in Figure 2, considering post-hoc tests. We observed 
differences between rumination, magnification and 
helplessness scores in all groups, suggesting the 
characteristics of pain catastrophizing are distinct 
according to the pain disorder.
Relations Between Pain Catastrophizing and 
Other Clinical Measures
Table 3 presents correlations between pain 
catastrophizing scores and depression, anxiety, sleep 
quality and pain levels for the clinical groups only. 
We decided to not include the HS group in order to 
understand how these measures are correlated in 
chronic pain syndromes. Not every patient had all 
the clinical measures (except for the BP:PCS), so we 
indicate the n included in each correlation performed. 
Accordingly, all clinical measures are positively 
correlated with pain catastrophizing as a global score, 
as well as its dimensions (rumination, magnification 
and helplessness), suggesting that the more clinical 
symptoms reported, the more catastrophic thoughts 
the patients present in relation to pain.
DISCUSSION
The between-group and within-group comparisons 
point out to the importance of paying attention to 
the dimensions of pain catastrophizing according 
to pain syndrome, also indicating that this may not 
be a unitary concept. In relation to rumination, we 
concluded that KOA patients were less catastrophic 
than FM and EM patients but more catastrophic than 
HS. Therefore, it could be observed that KOA patients 
have an intermediary level of rumination. Similarly, 
Table 3: Correlations between pain catastrophizing and depression, anxiety, sleep quality and pain level.
BDI-II
n = 92
STAI State  
n = 65






BP:PCS total 0.70** 0.50** 0.55** 0.33** 0.35**
BP:PCS rumination 0.73** 0.49** 0.59** 0.25** 0.35**
BP:PCS magnification 0.68** 0.49** 0.42** 0.21* 0.34**
BP:PCS helplessness 0.52** 0.39** 0.47** 0.32** 0.22**
BP:PCS = Brazilian Portuguese Pain Catastrophizing Scale; BDI-II = Beck Depression Inventory; STAI = State Trait Anxiety Inventory; 
PSQI = Pittsburgh Sleep Quality Index; VAS = Visual Analogue Scale. * p < 0.05; ** p < 0.01; all based on Pearson r index.
Figure 2: Differences within groups for the weighted (standardized) scores of rumination, magnification and helplessness 
of the BP:PCS. HS = healthy subjects; FM = fibromyalgia; MPS = myofascial pain syndrome; EM = endometriosis; 
CTTH = chronic tensional type headache; KOA = knee osteoarthritis; BP:PCS = Brazilian Portuguese Pain Catastrophizing 
Scale; SEM = standard error of the mean. * = indicates significant differences (p < 0.05), according to paired comparisons 
with Bonferroni correction.
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females with EM probably had an intermediary 
level of helplessness; although less catastrophic 
than HS, they did not reach the higher levels as for 
MPS, CTTH and FM patients. Taken together, these 
data indicate rumination would be more salient for 
KOA patients, whereas helplessness is more relevant 
in patients with EM.
Conversely, EM participants magnify their pain 
perception to a very high level, above FM, MPS, 
CTTC and KOA patients. Moreover, EM was the only 
syndrome to present more catastrophic thoughts of 
magnification than rumination and helplessness. 
Previous studies have demonstrated that pain 
catastrophizing predicted the persistence of pain in 
EM patients28. Here, we suggest magnification and 
exacerbation of pain would be the major problem 
these patients go through. In relation to MPS 
and CTTH, interestingly, there were no significant 
differences between these disorders in any aspect 
of pain catastrophizing. In addition, for both of them, 
rumination is the most salient catastrophizing factor. 
This may suggest that psychological and cognitive 
aspects of these two syndromes are similar. In fact, 
other authors29 discuss the presence of tender points, 
which characterize MPS, in patients with tension-type 
headache, contributing to its chronification and to the 
establishment of central sensitization syndromes.
Pain magnification was the best predictor of group 
differences in our sample. Interestingly, EM patients had 
the highest levels, followed by FM patients, who had 
more dysfunctional magnification than MPS, CTTH and 
KOA groups, and lastly, patients with CTTH, who had 
more pain magnification thoughts than HS, as well as 
KOA and MPS patients. In relation to FM patients, they 
presented a particular catastrophizing characteristic, 
considering helplessness was significantly lower 
compared to rumination and magnification, but was 
not a salient aspect in distinguishing these patients 
from those of the other clinical groups. Our research 
group have found that serum S100b protein and brain 
derived neurotrophic factor (BDNF) was associated 
with lower pressure-pain thresholds30, indicating 
a role a central sensitization FM patients. In our 
previous research, pain catastrophizing scores were 
similar to the present study (mean = 30.73). Another 
study found a significant relation between cortical 
excitability and pain catastrophizing was reported 
in MPS17. Taken together, these findings suggest 
that central nervous system physiological aspects 
(such as electrophysiological neuronal membrane 
state and neuroplasticity elements) may influence the 
level of catastrophizing. Patients with dysfunctional 
physiological state, especially when this persists over 
the time, becoming a dispositional characteristic, 
may be more vulnerable to catastrophizing thoughts. 
It should be pointed out that further causal studies 
need to test this hypothesis.
Moreover, we may not rule out the possibility that 
other characteristics, such as depression and anxiety, 
have an important influence on these differences. As our 
data also indicate, pain catastrophizing is closely related 
to clinical measures. Some of the correlations were 
moderate to strong (especially when one considers 
depression and anxiety). There is a debate in the 
literature with regard to pain catastrophizing being 
a separate element or a component of depression 
and anxiety symptoms31. Although there is no final 
conclusion in this matter, our findings highlight the 
importance of considering pain catastrophizing thoughts 
for predicting psychological aspects in chronic pain 
patients, including sleep quality. These thoughts may 
indicate: how cognitive aspects related to patient’s pain 
are structured; the evolution of the disorder and how 
pain deteriorates patient’s daily activities; and how 
pain management and treatment strategies impact 
on patient’s general health condition. The negative 
consequences of catastrophic thinking in functional 
aspects of patient’s daily activities may be indexed by 
the association we found with sleep quality. Although 
we must keep in mind the correlational aspect of this 
study and that sleep is only one of the basic daily 
functions, pain, sleep disturbance and catastrophic 
thoughts sum up their effects and may deteriorate 
the patient’s general functionality32. The relation 
of pain catastrophizing with pain level was also 
expected, although weak correlations were found 
here. In fact, catastrophizing thinking is associated 
with a distorted cognition with pessimistic beliefs 
about pain and is mainly regarded as a tendency 
or personality trait18, whereas pain levels assessed 
on a specific day may fluctuate greatly according to 
physiological, affective and social factors. In sum, 
although other clinical aspects are associated with 
pain catastrophizing, the present investigation aimed 
to characterize the pain catastrophizing of patients 
with painful syndromes using the theoretical approach 
of Sullivan et al.33. Other limitations are related to the 
lack of assessments of depression, anxiety and sleep 
quality in some of the syndromes, due to data was 
extracted from independent clinical trials, making it 
difficult to build a complete model so far.
CONCLUSIONS
This cross-sectional exploratory study investigated 
the association of chronic pain syndromes from diverse 
etiologies and distinct aspects of pain catastrophizing. 
Patients and healthy volunteers responded to the 
BP:PCS and to other clinical assessment instruments. 
HS clearly differ from clinical groups for all measures, 
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as expected. Magnification was the most sensitive 
measure to differentiate the groups, although 
helplessness, rumination and even the total score 
were particularly associated with some of the groups. 
These findings have implications for the theoretical 
aspects of pain catastrophizing, corroborating its 
multidimensional structure, and for practical issues, 
serving well for researchers and clinicians who need 
to consider cognitive and emotional aspects of pain 
perception in order to implement more appropriate 
interventions.
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